Novavax options trading jumps to highest in months

Novavax options activity surged on Friday, with total options volume reaching 13,629 contracts by 12:41 p.m. ET and put volume (12,111 contracts) the highest since Dec. 16, 2025. Shares were down 2.5% at $9.16, while the dominant July 31, 2026 $8 put traded 5,708 contracts (91 OI) and the July 17, 2026 $8 put traded 5,675 contracts (10,878 OI). The setup suggests heightened downside hedging/speculation despite the lack of a clear fundamental catalyst in the excerpt.

Analysis

The flow reads more like hedging than conviction buying: concentrated put activity at a single round strike usually signals an investor base that is already nervous and paying up to defend a downside level. That matters because when positioning gets crowded at one strike, the stock can become mechanically pinned near expiration unless there is a fresh fundamental catalyst; absent that, the market can mistake option volume for new information when it is often just balance-sheet or event risk insurance.

For NVAX, the immediate implication is not a clean directional short so much as a warning that sentiment is fragile and rally attempts may fade if they cannot reclaim the low-teens. Over 1-3 months, the more important question is whether this flow reflects repeated holder hedging or fresh short initiation; if it is the latter, downside can accelerate quickly because a small-cap biotech with limited fundamental momentum tends to reprice on liquidity rather than incremental news. If it is hedging, the move may already be partially owned and the stock can stabilize once that protection demand is satisfied.

Contrarian read: the consensus may be over-interpreting put volume as a bearish signal when it could simply be a large holder locking in downside ahead of an unknown event. In that case, the cleaner trade is volatility-aware rather than outright directional: if NVAX holds above the strike into expiry, the puts bleed and a relief rally can be sharp. What would falsify the bearish read is a decisive move back above $10 on improving volume or any evidence that the put open interest was closing/rolling rather than opening.

Key Decisions for Investors

• Do not short NVAX solely on this print; wait for confirmation from borrow data and a close below the $8 strike before expressing downside. If that break occurs, the cleaner expression is a July put spread (long $8 / short $6) for defined risk and 2:1+ payoff if momentum follows through.
• Relative-value: short NVAX against long XBI or IBB for a 1-3 month window if put demand persists. The basket should be less exposed to single-name event risk while NVAX remains vulnerable to liquidity-driven underperformance.
• If already long NVAX, use any bounce back toward $10-$10.50 to trim or overwrite with covered calls into the same expiry cluster. The crowded puts raise the odds of a stall rather than a clean trend advance.
• Set an alert on Jul 17 and Jul 31 expiry positioning: if spot is still above $8 and open interest remains elevated, consider that the bearish flow may be a hedge rather than a new directional bet, and avoid chasing the downside.